MyHand 2: An Active Hand Orthosis for Stroke Patients
Part of paid clinical trials in New York, New York.
- Sponsor
- Columbia University
- Study ID
- NCT04436042
- Status
- Recruiting
Conditions
- Hemiparesis
- Stroke
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- MyHand Device — DEVICEThese subjects may be asked to attend 1-40 sessions (approximately 90 mins) to trial a variety of device controls and/or components.
Study Details
This study is designed to further develop and test the hardware and software components of the MyHand device based on user feedback and results from our pilot study. The goal is to refine the device so that is more effective and easier for stroke patients to use to increase their hand function.
Key Dates
- Start date
- Mar 6, 2020
- Status verified
- Apr 2026
- Primary completion
- Jan 31, 2028
- Completion
- Jan 31, 2029
Study Design
- Enrollment
- 60 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- OTHER
Arms
- Experimental: MyHand TreatmentParticipants will use the MyHand device during repetitive grasp and release tasks.
Primary Outcome Measure
Device Usability and Utility Questionnaire Score [ Time Frame: Up to 1 year at study completion ]
Central Contacts
- Carley Teachout, MS212-305-6722
- Joel Stein, MD212-305-4818
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Columbia University Irving Medical Center | New York | New York | 10032 |
Find similar trials in New York, NY
By condition
By specialty
By research site
Related Studies
- Genetic and Environmental Risk Factors for Hemorrhagic StrokeRecruiting · State University of New York at Buffalo · Chicago, Illinois
- GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients With Patent Foramen Ovale (PFO): the REDUCE Post Approval StudyRecruiting · W.L.Gore & Associates · Tucson, Arizona
- Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABGPHASE3 · Recruiting · Icahn School of Medicine at Mount Sinai · Little Rock, Arkansas
- Transcranial Direct Current Stimulation (tDCS) With Verb Network Strengthening Treatment (VNeST) in Chronic AphasiaRecruiting · City University of New York · New York, New York